Skip to main navigation
Skip to search
Skip to main content
Sort by:
Keyphrases
Rheumatoid Arthritis
100%
Synoviocytes
100%
Fibroblast-like
100%
Enhancer of Zeste Homolog 2 (EZH2)
68%
ESM-1
56%
Small nucleolar RNA (snoRNA)
55%
Signaling Axis
50%
Epigenetic Regulation
50%
Autoimmune Disease Treatment
50%
PD-1 Blockade
50%
KRAS Signaling
50%
Mutational Heterogeneity
50%
Aptamer
43%
Mutant-selective
33%
Adaptive Resistance
33%
D-box
25%
H3K27me3
23%
Collagen-induced Arthritis Rat
17%
Polycomb Repressive Complex 2 (PRC2)
17%
KRAS-mutant Cancer
16%
KRAS Inhibition
16%
Kirsten Rat Sarcoma Viral Oncogene Homolog
16%
Exosome-mediated Delivery
16%
Tissue Context
16%
Context-dependent Signaling
16%
Scaffolding Function
14%
Autoimmune Disease
11%
Transcriptional Repression
11%
Rheumatoid Arthritis Treatment
11%
Monoclonal Antibody
10%
Arthritis
10%
Kinase Function
7%
SiRNA Delivery System
6%
SELEX
6%
Gene Promoter
6%
Aptamer-based
6%
Etanercept
6%
Therapeutic Efficacy
6%
Retinol-binding Protein 4 (RBP4)
6%
Tumor Necrosis Factor-α
6%
Transcriptome Analysis
6%
Biologic Disease-modifying Antirheumatic Drugs
6%
Interleukin-17 (IL-17)
6%
Ribosome Biogenesis
6%
Osteoarthritis
5%
High-level Expression
5%
Wear-and-Tear
5%
Aggressive Phenotype
5%
Mouse Model
5%
Rheumatoid Arthritis Patients
5%
Bone Destruction
5%
Disease Treatment
5%
Synovial Inflammation
5%
Inflammation
5%
Current Therapies
5%
Therapeutic Agents
5%
Functional Assay
5%
RNA Sequencing (RNA-seq)
5%
Therapeutic Effect
5%
Single-stranded DNA (ssDNA)
5%
Downstream Signaling
5%
Pathological Process
5%
Disease-modifying Antirheumatic Drugs (DMARDs)
5%
Expression Level
5%
Poor Response
5%
Mechanical Wear
5%
Synovial Tissue
5%
New Drug Targets
5%
Autoimmune Mechanism
5%
RBBP4
5%
Therapeutic Aptamers
5%
SiRNA Delivery
5%
Rheumatoid Osteoarthritis
5%
Delivery System
5%
New Therapeutic Approaches
5%
Immunology and Microbiology
Fibroblast-Like Synoviocyte
100%
Inflammatory Arthritis
100%
Ribonucleic Acid
58%
Autoimmune Disease
54%
Enzyme Activity
50%
Intestine Flora
50%
Akkermansia
50%
In Vitro
41%
Kinase
33%
Phosphotransferase
33%
Arthritis
25%
Mouse Model
24%
Transcription Factor EZH2
18%
Polycomb Repressive Complex 2
16%
Inflammation Response
16%
Antiinflammatory Activity
16%
Tumor Necrosis Factor
14%
Mucin
12%
Autoimmunity
10%
Osteoarthritis
8%
Monoclonal Antibody
8%
Immunotherapy
8%
RNA Sequence
8%
Biological Product
6%
Interleukin 17
6%
Lysine
6%
Etanercept
6%
Histone
6%
Gene Promoter
6%
Disease-Modifying Antirheumatic Drug
6%
Gene Expression Assay
6%
Retinoblastoma Binding Protein 4
6%
Biogenesis
6%
Biochemistry, Genetics and Molecular Biology
Fibroblast
100%
Aptamer
75%
Small Nucleolar RNA
58%
EZH2
50%
Epigenetics
50%
IRAK4
50%
KRAS
50%
Tumor Necrosis Factor
22%
Autoimmunity
22%
Polycomb Repressive Complex 2
20%
Allele
20%
Transcription Factor EZH2
18%
RNA
18%
Monoclonal Antibody
16%
Virus Oncogene
10%
Rat
10%
Isoform
10%
Carcinogenesis
10%
Tumor Progression
10%
Small GTPase
10%
Signal Transduction
8%
Promoter Region
8%
Upregulation
8%
Mouse Model
8%
Small Interfering RNA
8%
Mechanical Stress
8%
RBBP4
8%
Expression Level
8%
RNA Sequence
8%
Gene Promoter
6%
Systematic Evolution of Ligands by Exponential Enrichment
6%
Small Interfering RNA
6%
Histone H3
6%
Lysine
6%
Ribosome Biogenesis
6%
Retinoblastoma Binding Protein 4
6%
Etanercept
6%
Gene Expression Profiling
6%
Interleukin 17
6%